# About Kisspeptin: An Independent Research Digest

> About this Kisspeptin research digest: an independent editorial project summarizing the peer-reviewed literature on kisspeptin. Not a clinic, not a vendor, no medical advice.

What this project is, what it is not, and how it handles a compound that is still entirely investigational.

## What Rx Kisspeptin is

Rx Kisspeptin is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on kisspeptin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — the mechanism, the human trials, and the open questions, each claim traceable to a cited source on [the references page](/references).

## About the "rx" in the name

The "rx" in this site's name is editorial framing, not a service. It signals the position this publisher takes toward the literature — reading the research the way a careful clinician-minded reader would, leading every page with a plain-English on-ramp before the endocrinology deepens. It is not a claim that the site prescribes, dispenses, or supplies anything. Kisspeptin is investigational; there is nothing here to be prescribed, and no "rx" to fill.

## How we handle an investigational compound

Kisspeptin has no FDA, EMA or other regulatory approval for any indication, and it is not a dietary supplement despite how some sellers frame it. Every human study we summarize used pharmaceutical-grade peptide given under medical supervision, and we report doses only as research protocols — "studied at X in [population] by [route]" — never as a recommendation. Where the human anecdotal record is thin, we say so plainly, because the peptide is investigational rather than a sold consumer product. The sensitive material — sexual-desire and fertility reports — is carried only on [the effects page](/effects), clearly labeled anecdotal and never attached to a dose. Our aim is an accurate map of a signalling cascade, not advice about using it.

## Our editorial standard

We lead with what was measured and attribute it to the study that measured it. Every quantitative claim — every percentage, hormone level, pulse count and half-life — is cited to a real paper in the references. We use generic peptide names only and never reference drug brand names. We distinguish carefully between what controlled trials found and what people report, and between mechanism-grounded caution and proven clinical risk. The result is meant to be readable by a non-specialist and trustworthy to a specialist at the same time.

---

A plain-spoken reading room for the kisspeptin literature — the upstream KISS1 switch mapped one careful step at a time, the IVF and cycle-restoration trials set beside the PCOS biomarker data, the libido and fertility reports pinned to one side as clearly anecdotal, and the tachyphylaxis and investigational status stated in full; no clinic behind the desk and nothing here dosed, prescribed, or sold.